Resolute Integrity™ RSINT40012UXRecalls & reported problems
Medtronic, Inc. · Stent RSINT40012UX MicroTrac 4.00X12RX · Class 3 · Implant
All models of Resolute Integrity (52)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 1
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00643169037311), received between May 2, 2017 and Aug 12, 2020 — classified as 1 death, 2 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
Patient problems
- Death1
- Inflammation1
- Intimal Dissection1
- Reaction1
- Urticaria1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
DeathAug 12, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING A PROCEDURE, TWO RESOLUTE INTEGRITY RX CORONARY DRUG ELUTING STENTS WERE IMPLANTED TO TREAT LESIONS. IT WAS REPORTED THAT THE PATIENT DECEASED 5 YEARS POST IMPLANTATION OF THE RESOLUTE INTEGRITY STENTS. IT WAS STATED THAT THE CAUSE OF DEATH WAS CHOLECYSTITIS.
Patient problems: Death; Inflammation
MAUDE report 10395004 ↗InjuryNov 28, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PATIENT HAD ONE RESOLUTE INTEGRITY DRUG-ELUTING STENT IMPLANTED. APPROXIMATELY ONE WEEK POST IMPLANTATION THE PATIENT EXPERIENCED HIVES ON THEIR HANDS. THE PATIENT HAS BEEN TREATED WITH ANTIHISTAMINES HOWEVER THE HIVES STILL PERSIST AND ARE GETTING PAINFUL. PATIENT ALSO TAKES PLAVIX AND LIPITOR AND IS NOT AWARE OF ANY ALLERGIES THEY MAY HAVE. PATIENT SPECIFICALLY ASKED ABOUT THE ZOTAROLIMUS ON THE STENT AND WAS INFORMED BY TECHNICAL SERVICES THAT THE DRUG COMPLETELY ELUTES WITHIN 180 DAYS.
Patient problems: Reaction; Urticaria
MAUDE report 7062564 ↗InjuryMay 2, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PHYSICIAN IMPLANTED ONE RESOLUTE INTEGRITY DRUG ELUTING STENT TO TREAT CHEST PAIN EXPERIENCED BY THE PATIENT. IT WAS REPORTED THAT THE PATIENT CONTINUED TO HAVE CHEST PAIN DUE TO A SMALL EDGE DISSECTION. THIS WAS TREATED BY IMPLANTATION OF A SECOND RESOLUTE INTEGRITY DRUG ELUTING STENT.
Patient problems: Intimal Dissection
MAUDE report 6536321 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page